The Importance of Talent and Chemistry in New Patient-First Business Models

Forward-thinking life sciences companies are shifting to new patient-centered business models, leaving the traditional volume-first approach behind. This move has tremendous implications, not only for patients but also for the current workforce and future talent: life sciences companies need to design new roles and rethink their talent strategies, including the ways they recruit, train, motivate and retain the best teams.The shift from volume to valueThe historical model in life sciences has been based on selling products, where more was better - more products, more market share and then more profits. Value-based reimbursement - which is taking hold in Europe and the United States thanks to universal healthcare mandates - changes that model completely, to one that pays for outcomes.  Life sciences companies ’ new mission is now aligned with the broader healthcare ecosystem’s mission: putting patient care outcomes at the center and driving value for the entire healthcare system. Industry leaders are pivoting toward a patient- and consumer-centric model, partnering with risk-bearing healthcare provid ers and payers to provide cost-effective and efficient digitally enabled services. Connected devices, sensors, services, supportive social engagement and increasingly “aware” solutions are becoming more prevalent - meaning life sciences employees and future talent need a new, digital-first skill set.Accenture research projects that entirely new digital operating models (se...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news